T. K. Li

500 total citations
7 papers, 389 citations indexed

About

T. K. Li is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, T. K. Li has authored 7 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 3 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in T. K. Li's work include Spondyloarthritis Studies and Treatments (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). T. K. Li is often cited by papers focused on Spondyloarthritis Studies and Treatments (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). T. K. Li collaborates with scholars based in China and Hong Kong. T. K. Li's co-authors include Lai‐Shan Tam, E. K. Li, Tracy Y. Zhu, M. Li, Ying Ying Leung, E. W. Kun, Brian Tomlinson, Tanya T. W. Chu, Vivian Lee and KK Lee and has published in prestigious journals such as Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

T. K. Li

6 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. K. Li China	5	328	253	87	46	34	7	389
Ka Lung Yu China	7	319 1.0×	200 0.8×	47 0.5×	19 0.4×	31 0.9×	9	351
Hee Jung Ryu South Korea	11	191 0.6×	92 0.4×	41 0.5×	48 1.0×	34 1.0×	22	320
Shirley King Yee Ying China	8	221 0.7×	136 0.5×	19 0.2×	38 0.8×	23 0.7×	14	263
Gianna Mennillo Italy	6	232 0.7×	83 0.3×	52 0.6×	54 1.2×	40 1.2×	9	279
Marta Novella-Navarro Spain	9	172 0.5×	49 0.2×	41 0.5×	26 0.6×	18 0.5×	41	243
Tania Gudu Romania	7	220 0.7×	173 0.7×	136 1.6×	15 0.3×	16 0.5×	26	317
Guillermo Berbotto Argentina	5	210 0.6×	88 0.3×	33 0.4×	12 0.3×	16 0.5×	10	252
Risto Perich-Campos Peru	10	248 0.8×	139 0.5×	26 0.3×	24 0.5×	33 1.0×	34	305
Víctor R. Pimentel-Quiroz Peru	9	194 0.6×	81 0.3×	29 0.3×	17 0.4×	19 0.6×	38	236
D. Suchý Czechia	8	117 0.4×	67 0.3×	27 0.3×	40 0.9×	15 0.4×	21	205

Countries citing papers authored by T. K. Li

Since Specialization

Citations

This map shows the geographic impact of T. K. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. K. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. K. Li more than expected).

Fields of papers citing papers by T. K. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. K. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. K. Li. The network helps show where T. K. Li may publish in the future.

Co-authorship network of co-authors of T. K. Li

This figure shows the co-authorship network connecting the top 25 collaborators of T. K. Li. A scholar is included among the top collaborators of T. K. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. K. Li. T. K. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

So, Hon‐Cheong, Elaine Chow, T. K. Li, et al.. (2021). POS1222 FACTORS ASSOCIATED WITH USE OF TELEMEDICINE FOR FOLLOW-UP OF LUPUS NEPHRITIS IN THE COVID-19 OUTBREAK. Annals of the Rheumatic Diseases. 80. 895–895. 1 indexed citations

2.

Tam, Lai‐Shan, Qing Shang, E. W. Kun, et al.. (2014). The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial. Lara D. Veeken. 53(6). 1065–1074. 41 indexed citations

3.

Tam, Lai‐Shan, Qing Shang, E. W. Kun, et al.. (2013). FRI0412 The effects of golimumab on the progression of subclinical atherosclerosis and arterial stiffness in patients with ankylosing spondylitis – a randomized, placebo- controlled trial. Annals of the Rheumatic Diseases. 72. A513–A513.

4.

Li, E. K., Lai‐Shan Tam, Tracy Y. Zhu, et al.. (2009). Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?. Lara D. Veeken. 48(8). 892–898. 58 indexed citations

5.

Zhu, Tracy Y., Lai‐Shan Tam, Vivian Lee, et al.. (2008). Costs and quality of life of patients with ankylosing spondylitis in Hong Kong. Lara D. Veeken. 47(9). 1422–1425. 44 indexed citations

6.

Li, E. K., James F. Griffith, Vivian Lee, et al.. (2008). Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation. Lara D. Veeken. 47(9). 1358–1363. 42 indexed citations

7.

Tam, Lai‐Shan, Brian Tomlinson, Tanya T. W. Chu, et al.. (2008). Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation. Lara D. Veeken. 47(5). 718–723. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact